Effect of acute intravenous growth hormone-releasing factor on plasma prolactin in short children and patients with growth hormone deficiency. 1985

P G Chatelain, and G Sassolas, and N Catbeh, and S Bio-Laporte, and S Ferry, and B Claustrat, and M David, and R François

Four normal subjects and 54 growth hormone (GH)-deficient patients including 43 children with growth failure were given an intravenous bolus of growth hormone-releasing factor (GHRF). Plasma prolactin (Prl) and GH after GHRF were studied. Basal plasma Prl was either normal or elevated and could not predict the GH response to GHRF. A correlation was found, within the group with basal hyperprolactinemia, between basal Prl and the net Prl increase after GHRF. No correlation was found between the net GH and the net Prl increase after GHRF. Plasma Prl was significantly, although weakly, increased after GHRF in the normal subjects.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006130 Growth Disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth. Stunted Growth,Stunting,Disorder, Growth,Growth Disorder,Growth, Stunted,Stuntings
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013006 Growth Hormone A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized. Growth Hormone, Recombinant,Pituitary Growth Hormone,Recombinant Growth Hormone,Somatotropin,Somatotropin, Recombinant,Growth Hormone, Pituitary,Growth Hormones Pituitary, Recombinant,Pituitary Growth Hormones, Recombinant,Recombinant Growth Hormones,Recombinant Pituitary Growth Hormones,Recombinant Somatotropins,Somatotropins, Recombinant,Growth Hormones, Recombinant,Recombinant Somatotropin

Related Publications

P G Chatelain, and G Sassolas, and N Catbeh, and S Bio-Laporte, and S Ferry, and B Claustrat, and M David, and R François
November 1983, Lancet (London, England),
P G Chatelain, and G Sassolas, and N Catbeh, and S Bio-Laporte, and S Ferry, and B Claustrat, and M David, and R François
January 1985, Hormone research,
P G Chatelain, and G Sassolas, and N Catbeh, and S Bio-Laporte, and S Ferry, and B Claustrat, and M David, and R François
August 1985, Pediatrics,
P G Chatelain, and G Sassolas, and N Catbeh, and S Bio-Laporte, and S Ferry, and B Claustrat, and M David, and R François
February 1987, Endocrinologia japonica,
P G Chatelain, and G Sassolas, and N Catbeh, and S Bio-Laporte, and S Ferry, and B Claustrat, and M David, and R François
October 1988, European journal of pediatrics,
P G Chatelain, and G Sassolas, and N Catbeh, and S Bio-Laporte, and S Ferry, and B Claustrat, and M David, and R François
August 1989, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
P G Chatelain, and G Sassolas, and N Catbeh, and S Bio-Laporte, and S Ferry, and B Claustrat, and M David, and R François
December 1986, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
P G Chatelain, and G Sassolas, and N Catbeh, and S Bio-Laporte, and S Ferry, and B Claustrat, and M David, and R François
January 1999, The Medical letter on drugs and therapeutics,
P G Chatelain, and G Sassolas, and N Catbeh, and S Bio-Laporte, and S Ferry, and B Claustrat, and M David, and R François
October 1974, Endocrinologia japonica,
P G Chatelain, and G Sassolas, and N Catbeh, and S Bio-Laporte, and S Ferry, and B Claustrat, and M David, and R François
November 1989, Revista clinica espanola,
Copied contents to your clipboard!